LFTSF (LifeTech Scientific) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LFTSF LifeTech Scientific Corp LFTSF
95 GF Score
Price $0.23
GF Value $0.35
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

LFTSF
95GF Score
LifeTech Scientific Corp LFTSF
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is LifeTech Scientific (LFTSF) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of $0.23 is trading 33.3% below its estimated GF Value™ of $0.35.

Key valuation signals for LFTSF:

  • Interest Received:
  • GF Value™: $0.35 vs. price of $0.23 (33.3% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
95GF Score

Get the complete analysis for LFTSF

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price
$0.35
GF Value